About Us
In
2002 the Bill and Melinda Gates Foundation’s Global Health Programme*
granted a £20 million award to establish the SCI at Imperial College
London. The award has been directed to delivering treatment for
schistosomiasis and intestinal worms to millions of sub-Saharan Africans at
high risk of serious disease.
In 2006, the SCI was a founding partner of the Global Network for
Neglected Tropical Disease Control (www.gnntdc.org)
and expanded its remit to integrating the control or elimination of seven
NTDs.
By 2007, the SCI has facilitated delivery of approximately 40 million
treatments of praziquantel against schistosomiasis, and many more deworming
doses of albendazole. We have helped six countries establish national
control programmes, and several other countries implement smaller pilot
projects.
The American people, through
the United States Agency for International Development (USAID), are now
supporting SCI and others to further integrated NTD control in eight
countries, while Geneva Global (an international philanthropy company) is
funding SCI to promote integrated NTD control in Rwanda and Burundi. Through
integration SCI and its partner organizations cut costs, avoid duplication
and expand coverage to treat many more vulnerable people.
*The Bill and Melinda Gates Foundation’s
Global Health Programme is focused on reducing global health inequities by
accelerating the development, deployment and sustainability of health
interventions that will save lives and dramatically reduce the disease
burden in developing countries.
|